GeneDx Holdings Corp. is a genomics company. The Company operates, through its subsidiary, GeneDx, LLC, which is focused on exome and genome tests that translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It operates through GeneDx segment, which primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. Exome sequencing test options include XomeDx, XomeDx Plus, and XomeDxXpress. GeneDx genome sequencing evaluates the protein-coding and non-coding regions of an individual’s nuclear genome. GeneDx genome sequencing test options include GenomeSeqDx and GenomeXpress. It offers a menu of targeted variant testing options to meet the needs of families and healthcare providers. Its subsidiary, Fabric Genomics, Inc., specializes in artificial intelligence-powered genomic interpretation.
企業コードWGS
会社名GeneDx Holdings Corp
上場日Sep 04, 2020
設立日2020
最高経営責任者「CEO」Ms. Katherine A. Stueland
従業員数1000
証券種類Ordinary Share
決算期末Sep 04
本社所在地333 Ludlow Street
都市STAMFORD
証券取引所NASDAQ Global Select Consolidated
国United States of America
郵便番号06902
電話番号18887291206
ウェブサイトhttps://sema4.com/
企業コードWGS
上場日Sep 04, 2020
設立日2020
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし